Disclaimer: We may earn a commission if you make any purchase by clicking our links. Please see our detailed guide here.

Follow us on:

Google News
Whatsapp

Can Genetic Testing Help Evaluate the Risk of Heart Disease

IANS
IANS
Meet the voice behind Indo-Asian News Service (IANS), a storyteller navigating the currents of global events with precision and depth. Crafting narratives that bridge cultures, IANS brings you the pulse of the world in every word

Join the Opinion Leaders Network

Join the Techgenyz Opinion Leaders Network today and become part of a vibrant community of change-makers. Together, we can create a brighter future by shaping opinions, driving conversations, and transforming ideas into reality.

US researchers have launched a clinical trial in which genetic testing is used to identify men and women at risk of developing heart disease based on the makeup of their DNA.

If proven effective in clinical trials, this form of genetic testing may be adopted globally to prevent heart disease – the number one killer in the world.

“This should be the last century of heart disease,” said Robert Roberts, Medical Director of Cardiovascular Genomics for Dignity Health hospital in Arizona.

Throughout the duration of the study, the researchers will collect DNA samples from approximately 2,000 men and women aged between 40 and 60 with no known history of heart disease.

The DNA samples will then be analyzed to determine if the participants have genetic markers known to cause heart disease.

Once the DNA genotyping is completed, the team at Dignity will evaluate each participant’s genetic markers to determine if they have a low, medium, or high chance of developing heart disease.

Other health and lifestyle factors will also be considered when determining the participants’ risk of heart disease. These include hypertension, diabetes, high cholesterol, and whether the participant smokes or is physically active.

I am hopeful that through the results of this study we will be able to save even more lives in the future by implementing genetic testing for early prevention of coronary artery disease as routine clinical application. This approach would represent a paradigm shift in the prevention of this disease, – Roberts said.

Previously, studies have found strong DNA links to a heart attack.

Research has shown that high cholesterol levels from birth can be caused by a common genetic condition called familial hypercholesterolemia (FH). It can lead to a high risk of coronary heart disease from an early age, and some estimates suggest that by the age of 70, one in every two patients with FH would have had a coronary heart disease event.

In a paper published in the European Heart Journal, researchers from Monash University in Australia stated that DNA testing for FH in early adulthood via the public healthcare system could identify thousands more people with FH early, who could then be provided access to prevention that would save lives.

Join 10,000+ Fellow Readers

Get Techgenyz’s roundup delivered to your inbox curated with the most important for you that keeps you updated about the future tech, mobile, space, gaming, business and more.

Recomended

Partner With Us

Digital advertising offers a way for your business to reach out and make much-needed connections with your audience in a meaningful way. Advertising on Techgenyz will help you build brand awareness, increase website traffic, generate qualified leads, and grow your business.

Power Your Business

Solutions you need to super charge your business and drive growth

More from this topic